PLA–Inhibitor (stoPLA) – New class of NSAIDs for oral and transdermal inflammation treatment

PLA2 enzymes cleave phospholipids at the sn-2-position.

They exist as secreted and cytosolic forms. The cytosolic PLA2 (cPLA2) appears to play a key role in the pathway leading to the formation of inflammatory lipid mediators such as prostaglandins, leukotrienes and platelet activating factor, thus this enzyme is instrumental in pathogenic processes causing pain and inflammation. Presently topical application of glucocorticoids constitutes the most common way in the treatment of inflammatory dermatological disorders. Unfortunately, exposure of glucocorticoids has serious side effects, like skin atrophia, which limit their use as medication for inflammatory dermatitis. stoPLA is a new class of heteroaryl-substituted acetone derivatives for the effective inhibition of cytosolic PLA2 (cPLA2). These compounds effectively interact with the synthesis of prostaglandins and leukotrienes and reduce inflammatory processes. The new heteroaryl-substituted acetone derivatives have also an excellent solubility profile and are stable against metabolic inactivation through ketogroup reduction.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 10

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

The Sound of the Perfect Coating

Fraunhofer IWS Transfers Laser-based Sound Analysis of Surfaces into Industrial Practice with “LAwave”. Sound waves can reveal surface properties. Parameters such as surface or coating quality of components can be…

Customized silicon chips

…from Saxony for material characterization of printed electronics. How efficient are new materials? Does changing the properties lead to better conductivity? The Fraunhofer Institute for Photonic Microsystems IPMS develops and…

Acetylation: a Time-Keeper of glucocorticoid Sensitivity

Understanding the regulatory mechanism paves the way to enhance the effectiveness of anti-inflammatory therapies and to develop strategies to counteract the negative effects of stress- and age-related cortisol excess. The…

Partners & Sponsors